Re: Halted
|
|
Zenith Epigenetics
|
Mar 09, 2023 04:18PM
|
Re: Halted
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 12:05PM
|
Re: Halted
|
2
|
Zenith Epigenetics
|
Mar 09, 2023 11:59AM
|
Re: Halted
|
2
|
Zenith Epigenetics
|
Mar 09, 2023 11:39AM
|
Re: Halted
|
|
Zenith Epigenetics
|
Mar 09, 2023 11:05AM
|
Halted
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 10:58AM
|
Re: Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Feb 09, 2023 10:08AM
|
Re: Zenith trial partners
|
1
|
Zenith Epigenetics
|
Feb 02, 2023 06:54PM
|
Re: Zenith trial partners
|
2
|
Zenith Epigenetics
|
Feb 02, 2023 03:59PM
|
Re: Zenith trial partners
|
2
|
Zenith Epigenetics
|
Feb 02, 2023 12:31PM
|
A Leak
|
|
Resverlogix Corp.
|
Feb 02, 2023 10:30AM
|
Re: Zenith trial partners
|
2
|
Zenith Epigenetics
|
Feb 01, 2023 11:14PM
|
Re: Zenith trial partners
|
2
|
Zenith Epigenetics
|
Feb 01, 2023 08:07PM
|
Re: Zenith trial partners
|
2
|
Zenith Epigenetics
|
Jan 31, 2023 10:27AM
|
Re: Zenith trial partners
|
3
|
Zenith Epigenetics
|
Jan 30, 2023 06:05PM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
2
|
Zenith Epigenetics
|
Jan 29, 2023 11:16AM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 29, 2023 09:27AM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 27, 2023 02:47PM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
|
Zenith Epigenetics
|
Jan 27, 2023 11:18AM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
|
Zenith Epigenetics
|
Jan 27, 2023 10:20AM
|